The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010–2019
Authors:
- Jakhongir F. AlidjanovJAJakhongir F. Alidjanov
- Tommaso CaiTommaso Cai
- Riccardo BartolettiRBRiccardo Bartoletti
- Gernot BonkatGBGernot Bonkat
- Franck BruyèreFBFranck Bruyère
- Béla KövesBKBéla Köves
- Ekaterina KulchavenyaEKEkaterina Kulchavenya
- José Medina-PoloJMJosé Medina-Polo
- Kurt NaberKNKurt Naber
- Tamara PerepanovaTPTamara Perepanova
- Adrian PilatzAPAdrian Pilatz
- Zafer TandogduZTZafer Tandogdu
Open Access
- 22 February 2021
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 39 (9) , 3423-3432
Abstract
Purpose: To evaluate and report the complications, and to analyse antimicrobial stewardship aspects following prostate biopsies (P-Bx) based on the data from a 9-year global study.Methods: The primary outcome was to compare complications after P-Bx between patients of two cohorts: 2010–2014 and 2016–2019. Primary outcomes included symptoms of lower and severe/systemic urinary tract infection (LUTIS and SUTIS, respectively), and positive urine culture. Readmission to hospital after P-Bx, need for additional antimicrobial therapy, consumption of different antimicrobial agents for prophylaxis and therapy were evaluated. Studentsttest and chi-square test were used for comparative analyses.Results: Outcome data were available for 1615 men. Fluoroquinolones-based prophylaxis rate increased from 72.0% in 2010–2014 to 78.6% in 2015–2019. Overall rates of complications increased from 6 to 11.7% including an increase in symptomatic complications from 4.7 to 10.2%, mainly due to an increase in LUTIS. Rates of patients seeking additional medical help in primary care after P-Bx increased from 7.4 to 14.4%; cases requiring post P-Bx antibiotic treatment increased from 6.1 to 9.7%, most of which received fluoroquinolones. Transperineal P-Bx was significantly associated with LUTIS. Following transrectal P-Bx, 2.8% developed febrile infections and 4.0% required hospitalisation. Two men (0.12%) died after transrectal P-Bx due to sepsis.Conclusions: The rates of complications after P-Bx tended to increase in time, as well as rates of patients seeking additional medical help in the post-P-Bx period. To reduce the risk of infectious complications and to comply with the principles of antibiotic stewardship, clinicians should switch to the transperineal biopsy route.Keywords
This publication has 27 references indexed in Scilit:
- Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003–2013World Journal of Urology, 2015
- Infectious complications after prostate biopsy: Time to rethink our clinical practiceWorld Journal of Clinical Urology, 2015
- Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010World Journal of Urology, 2014
- Systematic Review of Complications of Prostate BiopsyEuropean Urology, 2013
- Infective Complications After Prostate Biopsy: Outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, A Prospective Multinational Multicentre Prostate Biopsy StudyEuropean Urology, 2013
- Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy-should we reassess our practices for antibiotic prophylaxis?Clinical Microbiology and Infection, 2012
- Complications After Prostate Biopsy: Data From SEER-MedicareJournal of Urology, 2011
- Best Practice Policy Statement on Urologic Surgery Antimicrobial ProphylaxisJournal of Urology, 2008
- Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibioticsInternational Journal of Antimicrobial Agents, 2006
- Urinary Tract Infection following Trans‐rectal Biopsy of the ProstateBritish Journal of Urology, 1975